Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.71 |
| ▸ | TPH1 | P17752 | 5/20 | 0.65 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | XIAP | P98170 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.60 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.59 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.59 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | PPARA | Q07869 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL597743 | 1.00 | LDHA (0.71) | LDHATPH1SLC7A5PTGS1ALPI | |
| SCHEMBL126195 | 1.00 | LDHA (0.71) | LDHATPH1SLC7A5PTGS1ALPI | |
| Hydrochloric Acid SCHEMBL16446949 | 0.98 | LDHA (0.69) | LDHATPH1SLC7A5PTGS1ALPI | |
| Hydrochloric Acid SCHEMBL6434789 | 0.98 | LDHA (0.69) | LDHATPH1SLC7A5PTGS1ALPI | |
| Hydrochloric Acid SCHEMBL6434786 | 0.98 | LDHA (0.69) | LDHATPH1SLC7A5PTGS1ALPI | |
| SCHEMBL6168594 | 0.95 | TPH1 (0.68) | LDHATPH1SLC7A5PTGS1ALPI | |
| SCHEMBL21803809 | 0.95 | LDHA (0.65) | LDHATPH1SLC7A5PTGS1ALPI | |
| SCHEMBL21803808 | 0.95 | LDHA (0.65) | LDHATPH1SLC7A5PTGS1ALPI | |
| Ethylene Glycol SCHEMBL28100674 | 0.95 | LDHA (0.65) | LDHATPH1SLC7A5PTGS1ALPI | |
| SCHEMBL8977526 | 0.94 | LDHA (0.63) | LDHATPH1SLC7A5PTGS1ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3381 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099341-A1 | BIOCONTAINMENT OF UNWANTED ENGINEERED CELLS USING NON-NATURAL AMINO ACIDS | SNIPR BIOME APS (DK) | 2026-05-15 | — | — | WO | claimed |
| US-20260035408-A1 | WKYMVm peptide analogues having six residues and uses thereof | RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV (KR) | 2026-02-05 | — | — | US | claimed |
| US-12534498-B2 | Compounds for use as apelin receptor antagonists | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2026-01-27 | — | — | US | claimed |
| EP-3448417-B1 | INSULIN DIMER-INCRETIN CONJUGATES | MERCK SHARP & DOHME LLC (US) | 2025-11-12 | — | — | EP | claimed |
| EP-4619043-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETED COMPOUNDS AND USE THEREOF | Perspective Therapeutics, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| WO-2025128149-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETED COMPOUNDS AND USE THEREOF | VIEWPOINT MOLECULAR TARGETING, INC. (US) | 2025-06-19 | — | — | WO | claimed |
| US-20250186630-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES | VIEWPOINT MOLECULAR TARGETING, INC. (US) | 2025-06-12 | — | — | US | claimed |
| WO-2025100520-A1 | PEPTIDE, PEPTIDE COMPLEX, PHARMACEUTICAL COMPOSITION, COMPOSITION FOR CELL CULTURE, AND COMPOSITION FOR MEDICAL USE, DIAGNOSTIC USE, OR RESEARCH USE | ペプチドリーム株式会社 | 2025-05-15 | — | — | WO | claimed |
| EP-4541891-A1 | NOVEL LRP1-BINDING PEPTIDE | Ichimaru Pharcos Co., Ltd. (JP) | 2025-04-23 | — | — | EP | claimed |
| WO-2025068348-A1 | PHARMACEUTICAL COMBINATION OF CXCR4 AND PD-1 INHIBITORS FOR TREATING CANCER | SPEXIS AG (CH) | 2025-04-03 | — | — | WO | claimed |
| CN-88100378-A | New peptidase inhibitors | — | 1988-10-05 | — | — | CN | claimed |
| CN-87101721-A | Bradykinin antagonists and their use | — | 1988-09-14 | — | — | CN | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0239874-A2 | Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their application | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-10-07 | — | — | EP | claimed |
| EP-0230242-A2 | Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-07-29 | — | — | EP | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
| US-4623715-A | ANTIDEPRESSANTS | HOECHST AKTIENGESELLESCHAFT (DE) | 1986-11-18 | — | — | US | claimed |
| EP-0179332-A2 | ZNS-active peptides acting on the cholinergetic system | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-04-30 | — | — | EP | claimed |
| US-4436910-A | SAPONIFICATION | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1984-03-13 | — | — | US | claimed |